Prime Medicine, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.6 | $3.0 | $0.0 | $0.0 | $0.0 |
| Operating income | -$208.3 | -$202.5 | -$204.8 | -$116.5 | -$84.5 |
| Net income | -$201.1 | -$195.9 | -$198.1 | -$121.8 | -$165.4 |
| Cash Flow Statement | |||||
| Free cash flow | -$167.1 | -$130.2 | -$174.1 | -$147.9 | -$38.2 |
Shares outstanding 180.6M · Free float 52.4%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.